Back
  1. Home
  2. Profile of Guy FAGHERAZZI (Unilu)
Profil

FAGHERAZZI Guy

University of Luxembourg

Main Referenced Co-authors
WILMES, Paul  (7)
OLLERT, Markus  (6)
Fischer, Aurélie (4)
Snoeck, Chantal J. (3)
Aguayo, Gloria (2)
Main Referenced Keywords
COVID-19 (7); SARS-CoV-2 (6); Humans (5); eHealth (3); General Medicine (3);
Main Referenced Unit & Research Centers
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) (2)
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) (2)
Luxembourg Centre for Systems Biomedicine (LCSB): Eco-Systems Biology (Wilmes Group) (2)
Integrative Research Unit: Social and Individual Development (INSIDE) > PEARL Institute for Research on Socio-Economic Inequality (IRSEI) (1)
LIH - Luxembourg Institute of Health (1)
Main Referenced Disciplines
Immunology & infectious disease (5)
Public health, health care sciences & services (4)
Microbiology (3)
Neurology (1)
Human health sciences: Multidisciplinary, general & others (1)

Publications (total 12)

The most downloaded
237 downloads
FAGHERAZZI, G., Fischer, A., Ismael, M., & DESPOTOVIC, V. (April 2021). Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice. Digital Biomarkers, 5 (1), 78-88. doi:10.1159/000515346 https://hdl.handle.net/10993/46861

The most cited

106 citations (OpenAlex)

FAGHERAZZI, G., Fischer, A., Ismael, M., & DESPOTOVIC, V. (April 2021). Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice. Digital Biomarkers, 5 (1), 78-88. doi:10.1159/000515346 https://hdl.handle.net/10993/46861

KLEE, M., AHO, V., MAY, P., Heintz-Buschart, A., LANDOULSI, Z., JONSDOTTIR, S., PAULY, C., PAVELKA, L., DELACOUR, L., KAYSEN, A., Krüger, R., WILMES, P., LEIST, A., Acharya, G., Aguayo, G., Alexandre, M., ALI, M., Ammerlann, W., ARENA, G., ... ZELIMKHANOV, G. (2024). Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome. Journal of Prevention of Alzheimer's Disease. doi:10.14283/jpad.2024.19
Peer reviewed

Santos da Silva, E., Servais, J.-Y., Kohnen, M., Arendt, V., Staub, T., The Con-Vince Consortium, The CoVaLux Consortium, Krüger, R., FAGHERAZZI, G., WILMES, P., Hübschen, J. M., OLLERT, M., Perez-Bercoff, D., & Seguin-Devaux, C. (06 October 2023). Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern. International Journal of Molecular Sciences, 24 (19), 14965. doi:10.3390/ijms241914965
Peer Reviewed verified by ORBi

de Nies, L., Galata, V., Martin-Gallausiaux, C., DESPOTOVIC, M., BUSI, S. B., Snoeck, C. J., DELACOUR, L., Budagavi, D. P., LACZNY, C. C., HABIER, J., Lupu, P.-C., HALDER, R., Fritz, J. V., MARQUES, T., Sandt, E., O'Sullivan, M. P., GHOSH, S., SATAGOPAM, V., Consortium, C.-V., ... WILMES, P. (09 March 2023). Altered infective competence of the human gut microbiome in COVID-19. Microbiome, 11 (1), 46. doi:10.1186/s40168-023-01472-7
Peer Reviewed verified by ORBi

Fischer, A., Badier, N., Zhang, L., Elbéji, A., WILMES, P., Oustric, P., Benoy, C., OLLERT, M., & FAGHERAZZI, G. (30 November 2022). Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. International Journal of Environmental Research and Public Health, 19 (23), 16018. doi:10.3390/ijerph192316018
Peer Reviewed verified by ORBi

BOUR, C. G. L. A., Ahne, A., Aguayo, G., Fischer, A., Marcic, D., Kayser, P., & FAGHERAZZI, G. (October 2022). Global diabetes burden: analysis of regional differences to improve diabetes care. BMJ Open Diabetes Research and Care, 10 (5), 003040. doi:10.1136/bmjdrc-2022-003040
Peer Reviewed verified by ORBi

Fischer, A., Zhang, L., Elbéji, A., WILMES, P., Oustric, P., Staub, T., Nazarov, P. V., OLLERT, M., & FAGHERAZZI, G. (August 2022). Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infectious Diseases, 9 (8), 397. doi:10.1093/ofid/ofac397
Peer Reviewed verified by ORBi

Capelle, C. M., Ciré, S., Domingues, O., ERNENS, I., Hedin, F., Fischer, A., Snoeck, C. J., Ammerlaan, W., Konstantinou, M., GRZYB, K., SKUPIN, A., Carty, C. L., HILGER, C., Gilson, G., Celebic, A., WILMES, P., Del Sol, A., Kaplan, I. M., BETSOU, F., ... HE, F. (2022). Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients. Cell Reports Medicine, 3 (4), 100600. doi:10.1016/j.xcrm.2022.100600
Peer reviewed

GOETZINGER, C. J., Alleaume, C., Schritz, A., Vrijens, B., Préau, M., FAGHERAZZI, G., & HUIART, L. (2022). Analysing breast cancer survivors' acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool. Frontiers in Pharmacology, 13, 889695. doi:10.3389/fphar.2022.889695
Peer Reviewed verified by ORBi

Linn, N., GOETZINGER, C. J., Regnaux, J.-P., Schmitz, S., Dessenne, C., FAGHERAZZI, G., & Aguayo, G. A. (September 2021). Digital Health Interventions among People Living with Frailty: A Scoping Review. Journal of the American Medical Directors Association, 22 (9), 1802 - 1812.e21. doi:10.1016/j.jamda.2021.04.012
Peer Reviewed verified by ORBi

BOUR, C. G. L. A., Ahne, A., Schmitz, S., PERCHOUX, C., Dessenne, C., & FAGHERAZZI, G. (27 May 2021). The Use of Social Media for Health Research Purposes: Scoping Review. Journal of Medical Internet Research, 23 (5), 25736. doi:10.2196/25736
Peer Reviewed verified by ORBi

FAGHERAZZI, G., Fischer, A., Ismael, M., & DESPOTOVIC, V. (April 2021). Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice. Digital Biomarkers, 5 (1), 78-88. doi:10.1159/000515346
Peer Reviewed verified by ORBi

WILMES, P., ZIMMER, J., Schulz, J., Glod, F., Veiber, L., MOMBAERTS, L., Rodrigues, B., AALTO, A., Pastore, J., Snoeck, C. J., OLLERT, M., FAGHERAZZI, G., MOSSONG, J., GONCALVES, J., SKUPIN, A., & NEHRBASS, U. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health. Europe, 4, 100056. doi:10.1016/j.lanepe.2021.100056
Peer Reviewed verified by ORBi

Contact ORBilu